|
EP2425853A1
(en)
|
2005-04-08 |
2012-03-07 |
Wyeth LLC |
Multivalent Pneumococcal Polysaccharide-Protein Conjugate Composition
|
|
US20070184072A1
(en)
|
2005-04-08 |
2007-08-09 |
Wyeth |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
|
LT2351578T
(lt)
*
|
2005-06-27 |
2017-04-10 |
Glaxosmithkline Biologicals S.A. |
Vakcinų gavimo būdas
|
|
GB0607088D0
(en)
*
|
2006-04-07 |
2006-05-17 |
Glaxosmithkline Biolog Sa |
Vaccine
|
|
BRPI0620460B8
(pt)
|
2005-12-22 |
2021-05-25 |
Glaxosmithkline Biologicals Sa |
uso de composição imunogênica para bebês, e, processo para produzir uma vacina
|
|
TW200806315A
(en)
|
2006-04-26 |
2008-02-01 |
Wyeth Corp |
Novel formulations which stabilize and inhibit precipitation of immunogenic compositions
|
|
US8808707B1
(en)
|
2006-05-08 |
2014-08-19 |
Wyeth Llc |
Pneumococcal dosing regimen
|
|
GB0822634D0
(en)
|
2008-12-11 |
2009-01-21 |
Novartis Ag |
Meningitis vaccines
|
|
DK2379734T3
(en)
*
|
2008-12-18 |
2018-04-23 |
Wyeth Llc |
Method for Controlling the Molecular Weight of Polysaccharide of Streptococcus Pneumoniae Serotype 19A
|
|
ES2749952T3
(es)
|
2008-12-18 |
2020-03-24 |
Wyeth Llc |
Procedimiento de control del peso molecular de polisacáridos de Streptococcus pneumoniae usando carbono
|
|
PL2411048T3
(pl)
|
2009-03-24 |
2020-11-16 |
Glaxosmithkline Biologicals Sa |
Adjuwantowe meningokokowe białko wiążące czynnik h
|
|
US20120064103A1
(en)
|
2009-03-24 |
2012-03-15 |
Novartis Ag |
Combinations of meningococcal factor h binding protein and pneumococcal saccharide conjugates
|
|
WO2010125480A1
(en)
*
|
2009-04-30 |
2010-11-04 |
Coley Pharmaceutical Group, Inc. |
Pneumococcal vaccine and uses thereof
|
|
GB201003922D0
(en)
|
2010-03-09 |
2010-04-21 |
Glaxosmithkline Biolog Sa |
Conjugation process
|
|
PT3170508T
(pt)
|
2010-06-04 |
2020-01-16 |
Wyeth Llc |
Formulações de vacinas
|
|
CA2803239A1
(en)
|
2010-06-25 |
2011-12-29 |
Novartis Ag |
Combinations of meningococcal factor h binding proteins
|
|
US20140112950A1
(en)
|
2011-03-02 |
2014-04-24 |
Manmohan Singh |
Combination vaccines with lower doses of antigen and/or adjuvant
|
|
AU2011384634A1
(en)
|
2011-12-29 |
2014-06-19 |
Novartis Ag |
Adjuvanted combinations of meningococcal factor H binding proteins
|
|
CN104519910B
(zh)
|
2012-03-07 |
2017-05-03 |
诺华股份有限公司 |
肺炎链球菌抗原的含佐剂制剂
|
|
JP2015509963A
(ja)
|
2012-03-08 |
2015-04-02 |
ノバルティス アーゲー |
Ｔｌｒ４アゴニストを含む混合ワクチン
|
|
KR102057217B1
(ko)
|
2012-06-20 |
2020-01-22 |
에스케이바이오사이언스 주식회사 |
다가 폐렴구균 다당류-단백질 접합체 조성물
|
|
EP2892553A1
(en)
|
2012-09-06 |
2015-07-15 |
Novartis AG |
Combination vaccines with serogroup b meningococcus and d/t/p
|
|
GB201218660D0
(en)
|
2012-10-17 |
2012-11-28 |
Glaxosmithkline Biolog Sa |
Immunogenic composition
|
|
KR20140075196A
(ko)
|
2012-12-11 |
2014-06-19 |
에스케이케미칼주식회사 |
다가 폐렴구균 다당류-단백질 접합체 조성물
|
|
US20150320852A1
(en)
|
2012-12-18 |
2015-11-12 |
Glaxosmithkline Biologicals Sa |
Conjugates for protecting against diphtheria and/or tetanus
|
|
KR20210032013A
(ko)
|
2014-01-21 |
2021-03-23 |
화이자 인코포레이티드 |
스트렙토코쿠스 뉴모니아에 피막 폴리사카라이드 및 그의 접합체
|
|
PT3096785T
(pt)
|
2014-01-21 |
2020-10-13 |
Pfizer |
Composições imunogénicas que compreendem antigénios de sacáridos capsulares conjugados e utilizações das mesmas
|
|
SI3096783T1
(sl)
*
|
2014-01-21 |
2021-09-30 |
Pfizer Inc. |
Kapsularni polisaharidi streptococcus pneumoniae in njihovi konjugati
|
|
US11160855B2
(en)
|
2014-01-21 |
2021-11-02 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
|
CN103893751B
(zh)
*
|
2014-03-26 |
2016-04-20 |
天津康希诺生物技术有限公司 |
一种肺炎球菌多糖蛋白缀合疫苗及其制备方法
|
|
EP3244917B1
(en)
|
2015-01-15 |
2023-04-19 |
Pfizer Inc. |
Immunogenic compositions for use in pneumococcal vaccines
|
|
TWI807252B
(zh)
|
2015-05-04 |
2023-07-01 |
美商輝瑞股份有限公司 |
Ｂ型鏈球菌多醣-蛋白質軛合物、製造軛合物之方法、含軛合物之免疫原性組成物、及其用途
|
|
KR102225282B1
(ko)
|
2015-07-21 |
2021-03-10 |
화이자 인코포레이티드 |
접합된 캡슐형 사카라이드 항원을 포함하는 면역원성 조성물, 그를 포함하는 키트 및 그의 용도
|
|
CA3005524C
(en)
|
2015-11-20 |
2023-10-10 |
Pfizer Inc. |
Immunogenic compositions for use in pneumococcal vaccines
|
|
GB201610599D0
(en)
|
2016-06-17 |
2016-08-03 |
Glaxosmithkline Biologicals Sa |
Immunogenic Composition
|
|
TWI770044B
(zh)
|
2016-08-05 |
2022-07-11 |
南韓商Ｓｋ生物科技股份有限公司 |
多價肺炎球菌多醣-蛋白質共軛物組成物(一)
|
|
SG11201900794PA
(en)
|
2016-08-05 |
2019-02-27 |
Sanofi Pasteur Inc |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
|
US10751402B2
(en)
|
2016-11-09 |
2020-08-25 |
Pfizer Inc. |
Immunogenic compositions and uses thereof
|
|
US11951165B2
(en)
|
2016-12-30 |
2024-04-09 |
Vaxcyte, Inc. |
Conjugated vaccine carrier proteins
|
|
MX2019007910A
(es)
|
2016-12-30 |
2019-12-05 |
Sutrovax Inc |
Conjugados de polipeptido-antigeno con aminoacidos no naturales.
|
|
MX392525B
(es)
|
2017-01-20 |
2025-03-12 |
Pfizer |
Composiciones inmunogenicas para su uso en vacunas neumococicas
|
|
KR20240169144A
(ko)
|
2017-01-31 |
2024-12-02 |
머크 샤프 앤드 돔 엘엘씨 |
다당류-단백질 접합체 제조 방법
|
|
KR20190121330A
(ko)
|
2017-02-24 |
2019-10-25 |
머크 샤프 앤드 돔 코포레이션 |
스트렙토코쿠스 뉴모니아에 폴리사카라이드-단백질 접합체의 면역원성의 증진
|
|
KR20240018698A
(ko)
|
2017-06-10 |
2024-02-13 |
인벤트프라이즈 인크. |
면역원성과 항원항체 결합성이 개선된 2가 또는 다가 접합체 다당류를 가진 다가 접합체 백신
|
|
US10729763B2
(en)
|
2017-06-10 |
2020-08-04 |
Inventprise, Llc |
Mixtures of polysaccharide-protein pegylated compounds
|
|
US11389540B2
(en)
|
2017-09-07 |
2022-07-19 |
Merck Sharp & Dohme Llc |
Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates
|
|
WO2019050813A1
(en)
|
2017-09-07 |
2019-03-14 |
Merck Sharp & Dohme Corp. |
ANTI-PNEUMOCOCCAL POLYSACCHARIDES AND THEIR USE IN IMMUNOGENIC CONJUGATES POLYSACCHARIDE-PROTEIN CARRIER
|
|
BR112020004509A8
(pt)
|
2017-09-07 |
2023-01-31 |
Merck Sharp & Dohme |
Conjugado polissacarídeo-proteína carreadora, composição imunogênica compreendendo o mesmo e uso do referido conjugado
|
|
BR112020011414B8
(pt)
|
2017-12-06 |
2023-01-31 |
Merck Sharp & Dohme |
Composições imunogênicas multivalentes compreendendo conjugados de proteína carreadora e polissacarídeo de s. pneumoniae
|
|
GB201721576D0
(en)
|
2017-12-21 |
2018-02-07 |
Glaxosmithkline Biologicals Sa |
Hla antigens and glycoconjugates thereof
|
|
BR112020014978A2
(pt)
|
2018-02-05 |
2020-12-22 |
Sanofi Pasteur, Inc. |
Composição de conjugado polissacarídeo-proteína pneumocócico multivalente
|
|
KR20230008923A
(ko)
|
2018-02-05 |
2023-01-16 |
사노피 파스퇴르 인코포레이티드 |
다가 폐렴구균성 다당류-단백질 접합체 조성물
|
|
EP3765516A2
(en)
*
|
2018-03-14 |
2021-01-20 |
Elstar Therapeutics, Inc. |
Multifunctional molecules and uses thereof
|
|
WO2020010000A1
(en)
|
2018-07-04 |
2020-01-09 |
Sutrovax, Inc. |
Improved methods for the preparation of immunogenic conjugates
|
|
DK3817775T3
(da)
|
2018-07-04 |
2024-09-16 |
Vaxcyte Inc |
Forbedringer i immunogene konjugater
|
|
WO2020010016A1
(en)
|
2018-07-04 |
2020-01-09 |
Sutrovax, Inc. |
Self-adjuvanted immunogenic conjugates
|
|
US11260119B2
(en)
|
2018-08-24 |
2022-03-01 |
Pfizer Inc. |
Escherichia coli compositions and methods thereof
|
|
US20220054632A1
(en)
|
2018-12-12 |
2022-02-24 |
Glaxosmithkline Biologicals Sa |
Modified carrier proteins for o-linked glycosylation
|
|
JP7585203B2
(ja)
|
2018-12-12 |
2024-11-18 |
ファイザー・インク |
免疫原性多重ヘテロ抗原多糖－タンパク質コンジュゲートおよびその使用
|
|
EP3897705A2
(en)
|
2018-12-19 |
2021-10-27 |
Merck Sharp & Dohme Corp. |
Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
|
|
CA3136278A1
(en)
|
2019-04-10 |
2020-10-15 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof
|
|
EP3757217A1
(en)
|
2019-06-27 |
2020-12-30 |
GlaxoSmithKline Biologicals S.A. |
Methods for protein purification
|
|
PH12022550110A1
(en)
|
2019-07-31 |
2022-12-12 |
Sk Bioscience Co Ltd |
Multivalent pneumococcal polysaccharide-protein conjugate compositions and methods of using the same
|
|
EP3777884A1
(en)
|
2019-08-15 |
2021-02-17 |
GlaxoSmithKline Biologicals S.A. |
Immunogenic composition
|
|
JOP20200214A1
(ar)
|
2019-09-03 |
2021-03-03 |
Serum Institute Of India Pvt Ltd |
تركيبات مولدة للمناعة ضد الأمراض المعوية وطرق لتحضيرها
|
|
US12473379B2
(en)
*
|
2019-09-06 |
2025-11-18 |
Serum Institute Of India Private Limited |
Method for obtaining purified bacterial polysaccharides
|
|
MX2022005252A
(es)
|
2019-11-01 |
2022-06-08 |
Pfizer |
Composiciones de escherichia coli y metodos de las mismas.
|
|
MX2022010350A
(es)
|
2020-02-23 |
2022-09-19 |
Pfizer |
Composiciones de esquerichia coli y sus metodos.
|
|
EP3900739A1
(en)
|
2020-04-21 |
2021-10-27 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Synthetic streptococcus pneumoniae saccharide conjugates to conserved membrane protein
|
|
EP4150104A1
(en)
*
|
2020-05-14 |
2023-03-22 |
Serum Institute Of India Private Limited |
Methods for simultaneous fragmentation and purification of bacterial polysaccharides
|
|
EP3919076A1
(en)
|
2020-06-02 |
2021-12-08 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Synthetic oligosaccharide vaccines against streptococcus pneumoniae with microparticle adjuvant formulations
|
|
BR112022023234A2
(pt)
|
2020-06-25 |
2023-01-03 |
Glaxosmithkline Biologicals Sa |
Proteínas de exotoxina a modificada
|
|
EP4192499A4
(en)
|
2020-08-10 |
2024-09-25 |
Inventprise, Inc. |
Multivalent pneumococcal glycoconjugate vaccines containing emerging serotype 24f
|
|
CA3192786A1
(en)
|
2020-08-26 |
2022-03-03 |
Pfizer Inc. |
Group b streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof
|
|
EP4237428A2
(en)
|
2020-10-27 |
2023-09-06 |
Pfizer Inc. |
Escherichia coli compositions and methods thereof
|
|
US12138302B2
(en)
|
2020-10-27 |
2024-11-12 |
Pfizer Inc. |
Escherichia coli compositions and methods thereof
|
|
CA3200602A1
(en)
|
2020-11-04 |
2022-05-12 |
Pfizer Inc. |
Immunogenic compositions for use in pneumococcal vaccines
|
|
US20230405137A1
(en)
|
2020-11-10 |
2023-12-21 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
|
US12357681B2
(en)
|
2020-12-23 |
2025-07-15 |
Pfizer Inc. |
E. coli FimH mutants and uses thereof
|
|
KR102610292B1
(ko)
*
|
2021-02-10 |
2023-12-04 |
에스케이바이오사이언스(주) |
스트랩토코커스 뉴모니애 다당류와 운반체 단백질의 접합체 제조 방법
|
|
WO2022234405A1
(en)
|
2021-05-03 |
2022-11-10 |
Pfizer Inc. |
Vaccination against bacterial and betacoronavirus infections
|
|
WO2022234416A1
(en)
|
2021-05-03 |
2022-11-10 |
Pfizer Inc. |
Vaccination against pneumoccocal and covid-19 infections
|
|
CA3221075A1
(en)
|
2021-05-28 |
2022-12-01 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
|
KR20230175284A
(ko)
|
2021-05-28 |
2023-12-29 |
화이자 인코포레이티드 |
접합된 피막 사카라이드 항원을 포함하는 면역원성 조성물 및 그의 용도
|
|
EP4452308A1
(en)
|
2021-12-22 |
2024-10-30 |
GlaxoSmithKline Biologicals S.A. |
Vaccine
|
|
WO2023135515A1
(en)
|
2022-01-13 |
2023-07-20 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
|
WO2023192997A2
(en)
*
|
2022-03-31 |
2023-10-05 |
The Children's Medical Center Corporation |
Immunogenic compositions for b-cell recall response to a polysaccharide antigen
|
|
IL316477A
(en)
|
2022-05-11 |
2024-12-01 |
Pfizer |
Process for producing vaccine formulations with preservatives
|
|
WO2024084397A1
(en)
|
2022-10-19 |
2024-04-25 |
Pfizer Inc. |
Vaccination against pneumoccocal and covid-19 infections
|
|
WO2024110827A1
(en)
|
2022-11-21 |
2024-05-30 |
Pfizer Inc. |
Methods for preparing conjugated capsular saccharide antigens and uses thereof
|
|
IL321062A
(en)
|
2022-11-22 |
2025-07-01 |
Pfizer |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
|
KR20250113501A
(ko)
|
2022-12-01 |
2025-07-25 |
화이자 인코포레이티드 |
폐렴구균 접합체 백신 제형
|
|
WO2024166008A1
(en)
|
2023-02-10 |
2024-08-15 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
|
GB202302579D0
(en)
|
2023-02-23 |
2023-04-12 |
Glaxosmithkline Biologicals Sa |
Immunogenic composition
|
|
CN121038808A
(zh)
|
2023-03-30 |
2025-11-28 |
辉瑞公司 |
包含缀合的荚膜糖抗原的免疫原性组合物及其用途
|
|
PE20252779A1
(es)
|
2023-04-14 |
2025-12-22 |
Pfizer |
Composiciones inmunogenas que comprenden antigenos de sacarido capsular conjugados y usos de estos
|
|
WO2024224266A1
(en)
|
2023-04-24 |
2024-10-31 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
|
EP4713008A2
(en)
|
2023-05-19 |
2026-03-25 |
GlaxoSmithKline Biologicals S.A. |
Methods for eliciting an immune response to respiratory syncycial virus and streptococcus pneumoniae infection
|
|
TW202527906A
(zh)
|
2023-09-14 |
2025-07-16 |
美商輝瑞股份有限公司 |
包含經結合之肺炎鏈球菌莢膜醣抗原之佐劑化致免疫性組成物及其用途
|
|
WO2025133971A1
(en)
|
2023-12-23 |
2025-06-26 |
Pfizer Inc. |
Improved methods for producing bacterial capsular saccharide glycoconjugates
|
|
TW202532099A
(zh)
|
2024-02-14 |
2025-08-16 |
美商默沙東有限責任公司 |
肺炎鏈球菌結合物疫苗及其使用方法
|
|
WO2025186705A2
(en)
|
2024-03-06 |
2025-09-12 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
|
TW202602467A
(zh)
|
2024-03-11 |
2026-01-16 |
美商輝瑞股份有限公司 |
包含經共軛之大腸桿菌糖的免疫原性組成物及其用途
|
|
WO2025219904A1
(en)
|
2024-04-19 |
2025-10-23 |
Pfizer Inc. |
Improved methods for producing glycoconjugates by reductive amination in aprotic solvent
|